PROVIDER PROFILE · NPI 1861469249

Joseph AntinMD

Hematopoietic Cell Transplantation and Cellular TherapyBoston, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

131

Distinct HCPCS

Medicare payment

$11K

PRESCRIBING · PART D · 2024

Total Rx claims

365

Beneficiaries

—

Total drug cost

$3.6M

Distinct drugs

Brand share

65.8%

Top prescribed drugs

Ruxolitinib Phosphate80 claims

Belumosudil Mesylate65 claims

Sulfamethoxazole/Trimethoprim62 claims

Acyclovir48 claims

Prednisone32 claims

QUALITY · MIPS · 2024

Final MIPS score

84.1

Quality

65.0

Cost

69.1

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.38%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$18K

Payment records

By payment type

Consulting Fee$17K

Food and Beverage$1K

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$225

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history